Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sedigheh Hatami

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|February 13, 2026
Metal-Organic Framework-Based Drug Delivery Systems for Cancer Therapy: A ReviewSedigheh Hatami, Khaled Chahrour, Joelle El Fakhouri, et al.
Plos One|October 12, 2012
Anti diabetic effect of CL 316,243 (a β3-adrenergic agonist) by down regulation of tumour necrosis factor (TNF-α) expressionMasoud Ghorbani, Mehdi Shafiee Ardestani, Sedigheh Hatami Gigloo, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|February 13, 2026
Metal-Organic Framework-Based Drug Delivery Systems for Cancer Therapy: A ReviewSedigheh Hatami, Khaled Chahrour, Joelle El Fakhouri, et al.
Plos One|October 12, 2012
Anti diabetic effect of CL 316,243 (a β3-adrenergic agonist) by down regulation of tumour necrosis factor (TNF-α) expressionMasoud Ghorbani, Mehdi Shafiee Ardestani, Sedigheh Hatami Gigloo, et al.
Pageof 1